Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Anebulo Pharmaceuticals, Inc. (ANEB)  
$3.04 0.00 (0.00%) as of 4:30 Tue 5/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 23,340,000
Market Cap: 70.95(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.71 - $3.49
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Anebulo Pharmaceuticals is a clinical-stage biotechnology company developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Co.'s primary product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, to address the unmet medical need for a specific antidote for ACI. ANEB-001 is an orally bioavailable absorbed treatment. Co.'s proprietary position in the treatment of ACI is protected by an issued patent and rights to a patent application covering various methods of use of the compound and delivery systems.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 13
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   22nw Fund, Lp 10% Owner   –       –       •   2023-12-18 4 GA $0.00 $0 I/I 300,000 5,366,290     -
   22nw Fund, Lp 10% Owner   –       –       •   2023-12-18 4 GD $0.00 $0 I/I 300,000 0     -
   22nw Fund, Lp 10% Owner   –       –       •   2023-11-13 4 A $0.00 $0 I/I 300,000 300,000     -
   22nw Fund, Lp 10% Owner   –       –       •   2022-09-28 4 A $2.81 $4,787,051 I/I 1,703,577 5,066,290     -
   22nw Fund, Lp See Explanation of Responses   –       –      –    2021-12-17 4 B $6.59 $2,634 I/I 400 3,362,713 0.01 -44%     
   22nw Fund, Lp See Explanation of Responses   –       –      –    2021-12-14 4 B $5.90 $2,429 I/I 412 3,362,313 0.01 -36%     
   22nw Fund, Lp See Explanation of Responses   –       –      –    2021-12-03 4 B $5.93 $26,685 I/I 4,500 3,361,901 0.01 -20%     
   22nw Fund, Lp See Explanation Response   –       –      –    2021-12-02 4 B $5.30 $73,331 I/I 13,836 3,357,401 0.01 -20%     
   22nw Fund, Lp See Explanation of Responses   –       –       •   2021-05-06 4/A A $7.00 $4,999,750 I/I 714,250 3,343,565     -
   22nw, Lp See Explanation of Responses   –       –       •   2021-05-06 4 A $7.00 $5,000,002 I/I 714,286 3,343,601     -
   22nw, Lp 10% Owner   –       –       •   2021-05-06 3 IO $0.00 $0 I/I 0 7,283,843     -
   Lawler Joseph F. Director   –       •      –    2021-05-06 3 IO $0.00 $0 D/D 0 12,000,000     -
   Schneeberger Daniel Chief Executive OfficerOfficer   •       –      –    2021-05-06 3 IO $0.00 $0 D/D 0 982,500     -

  13 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed